Literature DB >> 9778272

Presence of 4-hydroxynonenal in cerebrospinal fluid of patients with sporadic amyotrophic lateral sclerosis.

R G Smith1, Y K Henry, M P Mattson, S H Appel.   

Abstract

A marker of lipid peroxidation 4-hydroxynonenal (HNE) was elevated in the cerebrospinal fluid (CSF) of a patient with sporadic amyotrophic lateral sclerosis (sALS) compared with that of most patients with other neurological diseases. Such elevations of HNE were sufficient to kill cyclic adenosine monophosphate (cAMP)-differentiated motor neuron hybrid cells in vitro, and anti-oxidants prevented this HNE-dependent cell death. These data suggest that oxidative stress and lipid peroxidation are associated with and may promote motor neuron degeneration in sALS.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9778272     DOI: 10.1002/ana.410440419

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  54 in total

1.  S100B protein and 4-hydroxynonenal in the spinal cord of wobbler mice.

Authors:  Valentina Corvino; Rita Businaro; Maria Concetta Geloso; Paolo Bigini; Valentina Cavallo; Elena Pompili; Tiziana Mennini; Lorenzo Fumagalli; Fabrizio Michetti
Journal:  Neurochem Res       Date:  2003-02       Impact factor: 3.996

2.  Different roles of radical scavengers--ascorbate and urate in the cerebrospinal fluid of amyotrophic lateral sclerosis patients.

Authors:  Ivan Spasojević; Zorica Stević; Aleksandra Nikolić-Kokić; David R Jones; Dusko Blagojević; Mihajlo B Spasić
Journal:  Redox Rep       Date:  2010       Impact factor: 4.412

Review 3.  [Amyotrophic lateral sclerosis. Current clinical trials and underlying pathomechanisms].

Authors:  K Kollewe; R Dengler; S Petri
Journal:  Nervenarzt       Date:  2008-06       Impact factor: 1.214

Review 4.  Stem cell-derived motor neurons: applications and challenges in amyotrophic lateral sclerosis.

Authors:  Jason R Thonhoff; Luis Ojeda; Ping Wu
Journal:  Curr Stem Cell Res Ther       Date:  2009-09       Impact factor: 3.828

Review 5.  Measures and markers in amyotrophic lateral sclerosis.

Authors:  Merit Cudkowicz; Muhammad Qureshi; Jeremy Shefner
Journal:  NeuroRx       Date:  2004-04

6.  Metabolomic analysis and signatures in motor neuron disease.

Authors:  Steve Rozen; Merit E Cudkowicz; Mikhail Bogdanov; Wayne R Matson; Bruce S Kristal; Chris Beecher; Scott Harrison; Paul Vouros; Jimmy Flarakos; Karen Vigneau-Callahan; Theodore D Matson; Kristyn M Newhall; M Flint Beal; Robert H Brown; Rima Kaddurah-Daouk
Journal:  Metabolomics       Date:  2005       Impact factor: 4.290

Review 7.  Disturbance of redox homeostasis as a contributing underlying pathomechanism of brain and liver alterations in 3-hydroxy-3-methylglutaryl-CoA lyase deficiency.

Authors:  Guilhian Leipnitz; Carmen Regla Vargas; Moacir Wajner
Journal:  J Inherit Metab Dis       Date:  2015-06-04       Impact factor: 4.982

8.  Increased ROS Level in Spinal Cord of Wobbler Mice due to Nmnat2 Downregulation.

Authors:  Pascal Röderer; Lara Klatt; Felix John; Verena Theis; Konstanze F Winklhofer; Carsten Theiss; Veronika Matschke
Journal:  Mol Neurobiol       Date:  2018-03-16       Impact factor: 5.590

Review 9.  Amyotrophic lateral sclerosis: progress and prospects for treatment.

Authors:  Michel Dib
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 10.  Nrf2--a therapeutic target for the treatment of neurodegenerative diseases.

Authors:  Delinda A Johnson; Jeffrey A Johnson
Journal:  Free Radic Biol Med       Date:  2015-08-14       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.